By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Cardiovascular Company624.36B60.26%
Medical Care Solutions Company211.24B20.39%
Blood and Cell Technology Company200.28B19.33%
Adjustment amount298M0.03%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
United States342.9B33.09%
Europe218.29B21.07%
Japan217.21B20.96%
Asia and others120.05B11.59%
China84.97B8.20%
Americas52.76B5.09%
View all
